ID: ALA391982

Max Phase: Preclinical

Molecular Formula: C8H8ClN3S

Molecular Weight: 213.69

Molecule Type: Small molecule

Representations

Synonyms (1): 2-(4-Chlorobenzylidene)Hydrazinecarbothioamide
Synonyms from Alternative Forms(1):

Canonical SMILES:  NC(=S)N/N=C/c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C8H8ClN3S/c9-7-3-1-6(2-4-7)5-11-12-8(10)13/h1-5H,(H3,10,12,13)/b11-5+

Standard InChI Key:  FABQYDLGFZXBIK-VZUCSPMQSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 213.69

Molecular Weight (Monoisotopic): 213.0127

AlogP: 1.51

#Rotatable Bonds: 2

Polar Surface Area: 50.41

Molecular Species: NEUTRAL

HBA: 2

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 3

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 11.71

CX Basic pKa: 1.87

CX LogP: 2.27

CX LogD: 2.27

Aromatic Rings: 1

Heavy Atoms: 13

QED Weighted: 0.44

Np Likeness Score: -2.36

References

1. Karki SS, Thota S, Darj SY, Balzarini J, De Clercq E..  (2007)  Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.,  15  (21): [PMID:17765549] [10.1016/j.bmc.2007.08.014]

2. Lee KC, Thanigaimalai P, Sharma VK, Kim MS, Roh E, Hwang BY, Kim Y, Jung SH..  (2010)  Structural characteristics of thiosemicarbazones as inhibitors of melanogenesis.,  20  (22): [PMID:20863702] [10.1016/j.bmcl.2010.08.114]

3. Aslam MA, Mahmood SU, Shahid M, Saeed A, Iqbal J..  (2011)  Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.,  46  (11): [PMID:21981981] [10.1016/j.ejmech.2011.09.009]

4. da Silva JB, Navarro DM, da Silva AG, Santos GK, Dutra KA, Moreira DR, Ramos MN, Espíndola JW, de Oliveira AD, Brondani DJ, Leite AC, Hernandes MZ, Pereira VR, da Rocha LF, de Castro MC, de Oliveira BC, Lan Q, Merz KM..  (2015)  Thiosemicarbazones as Aedes aegypti larvicidal.,  100  [PMID:26087027] [10.1016/j.ejmech.2015.04.061]

5. Soares MA, Almeida MA, Marins-Goulart C, Chaves OA, Echevarria A, de Oliveira MCC..  (2017)  Thiosemicarbazones as inhibitors of tyrosinase enzyme.,  27  (15): [PMID:28583798] [10.1016/j.bmcl.2017.05.057]

6. Ferreira FB, Pereira TM, Souza DLN, Lopes DS, Freitas V, Ávila VMR, Kümmerle AE, Sant'Anna CMR..  (2017)  Structure-Based Discovery of Thiosemicarbazone Metalloproteinase Inhibitors for Hemorrhage Treatment in Snakebites.,  8  (11): [PMID:29152044] [10.1021/acsmedchemlett.7b00186]

7. Mathew B, Baek SC, Grace Thomas Parambi D, Pil Lee J, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H..  (2018)  Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.,  9  (11): [PMID:30568755] [10.1039/C8MD00399H]

8. Hałdys K, Latajka R..  (2019)  Thiosemicarbazones with tyrosinase inhibitory activity.,  10  (3): [PMID:31015905] [10.1039/C9MD00005D]

9. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA..  (2018)  Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.,  362  (6419): [PMID:30523084] [10.1126/science.aat9446]

Source

Source(2):

• Scientific Literature
• Winzeler Lab Plasmodium Screening Data